# The CONFORM Pivotal Trial

Study · id `cardio:ct-nct05147792` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05147792](<https://clinicaltrials.gov/study/NCT05147792>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05147792

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1600 participants.

## Technical summary

Registry record NCT05147792. Randomized; no masking; primary purpose prevention. Start 2022-05-26 (actual); primary completion 2028-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1600 participants (planned count; ClinicalTrials.gov record NCT05147792, source copy `cardio:ctgov-nct05147792-2026-09-25`, retrieved 2026-10-26)
- Started: 2022-05-26 (actual) (ClinicalTrials.gov record NCT05147792, source copy `cardio:ctgov-nct05147792-2026-09-25`, retrieved 2026-10-26)
- Primary completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT05147792, source copy `cardio:ctgov-nct05147792-2026-09-25`, retrieved 2026-10-26)
- Completion: 2031-12 (anticipated) (ClinicalTrials.gov record NCT05147792, source copy `cardio:ctgov-nct05147792-2026-09-25`, retrieved 2026-10-26)
- Countries: United States; Czechia; France; Georgia; Germany; Uzbekistan (ClinicalTrials.gov record NCT05147792, source copy `cardio:ctgov-nct05147792-2026-09-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05147792-2026-09-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: The CONFORM Pivotal Trial
- Condition: Atrial Fibrillation
- Condition: Stroke
- Intervention (Device): CLAAS
- Intervention (Device): WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
- Lead sponsor: Conformal Medical, Inc
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 4456d3ee4ea2c5707b5c8336d01ca4fd1778e6f24cf59ebf4619a99c023ae666
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
